...
首页> 外文期刊>Annual Research & Review in Biology >The systematic Review of Quinolones Resistance of Escherichia coli Isolated from Urinary Tract Infections in Iran over the Last Ten Years (2001-2011)
【24h】

The systematic Review of Quinolones Resistance of Escherichia coli Isolated from Urinary Tract Infections in Iran over the Last Ten Years (2001-2011)

机译:过去十年(2001-2011年)从伊朗泌尿道感染中分离出来的大肠杆菌对喹诺酮类药物的耐药性的系统评价

获取原文
           

摘要

Aims: Urinary tract infection (UTI) is one the most common bacterial infection and Escherichia coli ( E. coli ) has been isolated from the majority of UTI cases. On the other hand, the rate of UTIs caused by quinolones resistant E. coli is increasing worldwide. We aimed to perform a systematic review of quinolones resistance of E. coli isolated from urinary tract infections in Iran over last ten years. Methodology: In this study the data of 53 cross-sectional studies from 2001 to 2011 on quinolones resistance of E. coli isolated from UTIs in 22 cities of Iran was collected. The data was statistical analyzed using SPSS version 18 and Stata software. Results: Of 53 studies, 44, 41, 8 and 6 studies tested ciprofloxacin, nalidixic acid, norfloxacin and ofloxacin, respectively. Majority of studies, 31(58.5%), was done on out-patients. For susceptibility testing of isolates, 49 and 4 of studies used disk diffusion and E test method, respectively. Forty six of studies (86.8%) used mid-stream urinesample, while the rest used other methods for sampling including catheter, suprapubic aspiration and urine bag. Overall resistance for nalidixic acid, ciprofloxacin, norfloxacin and ofloxacin were 42.3%, 28.2%, 48.5% and 24.1%, respectively. The results of most studies were significantly heterogenic (P<0.001). Conclusion: Results indicated the resistance to quinolones including ciprofloxacin, norfloxacin and nalidixic acid is quite high. Given the increased resistance to these drugs, urine culture and antimicrobial susceptibility testing are essential for the treatment of UTIs.
机译:目的:尿路感染(UTI)是最常见的细菌感染之一,并且已从大多数UTI病例中分离出大肠杆菌(E. coli)。另一方面,由喹诺酮类耐药的大肠杆菌引起的UTI发生率在世界范围内正在增加。我们的目标是对过去十年来从伊朗的尿路感染中分离出来的大肠杆菌的喹诺酮类药物耐药性进行系统评价。方法:本研究收集了2001年至2011年间53项横断面研究数据,这些数据涉及伊朗22个城市从UTI分离的大肠杆菌对喹诺酮类药物的耐药性。使用SPSS 18版和Stata软件对数据进行统计分析。结果:在53项研究中,有44项,41项,8项和6项研究分别测试了环丙沙星,萘啶酸,诺氟沙星和氧氟沙星。多数研究针对门诊患者,共31项(58.5%)。对于分离物的药敏试验,有49和4个研究分别使用了圆盘扩散法和E检验法。四十六项研究(86.8%)使用了中游尿液样本,其余的使用了其他采样方法,包括导管,耻骨上抽吸术和尿袋。萘啶酸,环丙沙星,诺氟沙星和氧氟沙星的总耐药性分别为42.3%,28.2%,48.5%和24.1%。大多数研究的结果都是异质性的(P <0.001)。结论:结果表明对环丙沙星,诺氟沙星和萘啶酸的喹诺酮类药物耐药性较高。鉴于对这些药物的抵抗力增强,尿培养和抗菌药敏试验对于治疗UTI至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号